A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

Sistani joined WeightWatchers as CEO more than two years ago. During her tenure, she led the company's recent moves into the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

Weight loss drugs have become popular due to social media and celebrities using them to shed excess pounds quickly. Although ...

Congress is pushing companies like Ozempic and Wegovy, which make weight loss drugs that have changed the lives of millions ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...

International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...